Löhr, J., Haas, S., & Jäger, D. (2012). Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: A randomized controlled phase II trial. Annals of oncology, 23(5), . https://doi.org/10.1093/annonc/mdr379
Chicago Style (17th ed.) CitationLöhr, J.-Matthias, Stephan Haas, and Dirk Jäger. "Cationic Liposomal Paclitaxel Plus Gemcitabine or Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Randomized Controlled Phase II Trial." Annals of Oncology 23, no. 5 (2012). https://doi.org/10.1093/annonc/mdr379.
MLA (9th ed.) CitationLöhr, J.-Matthias, et al. "Cationic Liposomal Paclitaxel Plus Gemcitabine or Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Randomized Controlled Phase II Trial." Annals of Oncology, vol. 23, no. 5, 2012, https://doi.org/10.1093/annonc/mdr379.